Mushrooms have travelled from folklore to lab benches. Not all of them made it with evidence intact For thousands of years, cultures across East Asia and beyond treated certain mushrooms as more than food, using them as tonics for stamina, sleep and resilience, long before anyone could measure inflammation, neurotransmitters, or markers of brain injury in a blood sample (Venturella et al., 2021). The modern story is not that ancient tradition was “right about everything.” It

If you are living with Alzheimer’s disease (AD), mild cognitive impairment (MCI), or you are caring for someone who is, research headlines do not land like abstract science. They land like hope, pressure, and sometimes fear. A new study can feel like a lifeline. It can also feel like yet another promise that may not hold up. That is why the recent EVANTHEA randomised controlled trial (RCT) preprint has created such a surge across clinician and health-innovation circles, inclu

Early 2026 is a good moment to reset the way we talk about neurodegeneration. Not with slogans, and not with false certainty, but with a practical question that respects real lives: what has actually held up in human studies, and what is worth watching next? In clinic, we treat research like a set of road signs. Some are solid and well-lit. Some are temporary. Some are misleading. The job is not to pretend we have a map for every side street. The job is to keep you off the cl